Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NVO
NVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVO News
Novo Nordisk to Increase Investment in Ireland for Wegovy Production
2d ago
seekingalpha
Investment Potential of Novo Nordisk and AbbVie
22h ago
Fool
Investment Outlook for Pharmaceutical Sector
22h ago
NASDAQ.COM
Universities Experience Financial Pressure Despite Strong Results
1d ago
Barron's
Market Rebounds as Eli Lilly Prepares for New Drug Launch
1d ago
CNBC
Novo Nordisk Addresses Drug Compounding Issues Amid Competition
1d ago
stocktwits
Pfizer's Dividend Yield Exceeds Market Average
2d ago
Fool
Pfizer's Long-Acting GLP-1 Weight Loss Drug Shows Promising Trial Results
2d ago
NASDAQ.COM
European Pharma Companies Look Ahead to 2026
2d ago
CNBC
Eli Lilly Stockpiles $1.5 Billion in Weight-Loss Drug Inventory
2d ago
Benzinga
Viking Therapeutics' VK2735 Sees Strong Demand Amid Novo Nordisk Launch
2d ago
stocktwits
Novo Nordisk Launches Wegovy in Vials to Compete
2d ago
Benzinga
McDonald's CEO Faces Challenge from GLP-1 Weight-Loss Drugs
2d ago
Yahoo Finance
Novo Nordisk Expands Manufacturing in Ireland for Wegovy
3d ago
stocktwits
Eli Lilly and Novo Nordisk's Weight Loss Drug Competition
3d ago
Fool
Eli Lilly and Novo Nordisk Compete in Weight Loss Drug Market
3d ago
NASDAQ.COM
Show More News
